BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, Zhu W, Sporrer D, Hehlgans T, Kreutz M. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:640-645. [PMID: 24492144 DOI: 10.1016/j.bbmt.2014.01.030] [Cited by in Crossref: 302] [Cited by in F6Publishing: 281] [Article Influence: 37.8] [Reference Citation Analysis]
Number Citing Articles
1 Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271-285. [PMID: 28303904 DOI: 10.1038/nrc.2017.13] [Cited by in Crossref: 370] [Cited by in F6Publishing: 348] [Article Influence: 74.0] [Reference Citation Analysis]
2 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
3 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
4 Young BA, Hanson KE, Gomez CA. Molecular Diagnostic Advances in Transplant Infectious Diseases. Curr Infect Dis Rep 2019;21:52. [PMID: 31773290 DOI: 10.1007/s11908-019-0704-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
5 Bertolini M, Dongari-Bagtzoglou A. The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis. J Fungi (Basel) 2019;5:E87. [PMID: 31546600 DOI: 10.3390/jof5040087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 2017;23:820-9. [PMID: 28192251 DOI: 10.1016/j.bbmt.2017.02.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 15.6] [Reference Citation Analysis]
7 Biehl LM, Garzetti D, Farowski F, Ring D, Koeppel MB, Rohde H, Schafhausen P, Stecher B, Vehreschild MJGT. Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients. PLoS One 2019;14:e0215428. [PMID: 30986251 DOI: 10.1371/journal.pone.0215428] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
8 Levinson A, Pinkney K, Jin Z, Bhatia M, Kung AL, Foca MD, George D, Garvin JH, Sosna J, Karamehmet E, Robinson C, Satwani P. Acute Gastrointestinal Graft-vs-Host Disease Is Associated With Increased Enteric Bacterial Bloodstream Infection Density in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients. Clin Infect Dis 2015;61:350-7. [DOI: 10.1093/cid/civ285] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
9 Whangbo J, Ritz J, Bhatt A. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:183-90. [PMID: 27526283 DOI: 10.1038/bmt.2016.206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
10 Riwes M, Reddy P. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 2020;57:1-6. [DOI: 10.1053/j.seminhematol.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Beak JA, Park MJ, Kim SY, Jhun J, Woo JS, Choi JW, Na HS, Lee SK, Choi JY, Cho ML. FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance. J Transl Med 2022;20:104. [PMID: 35216600 DOI: 10.1186/s12967-022-03303-z] [Reference Citation Analysis]
12 Han L, Zhang H, Chen S, Zhou L, Li Y, Zhao K, Huang F, Fan Z, Xuan L, Zhang X, Dai M, Lin Q, Jiang Z, Peng J, Jin H, Liu Q. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2019;25:1944-55. [PMID: 31299215 DOI: 10.1016/j.bbmt.2019.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
13 Doki N, Suyama M, Sasajima S, Ota J, Igarashi A, Mimura I, Morita H, Fujioka Y, Sugiyama D, Nishikawa H, Shimazu Y, Suda W, Takeshita K, Atarashi K, Hattori M, Sato E, Watakabe-Inamoto K, Yoshioka K, Najima Y, Kobayashi T, Kakihana K, Takahashi N, Sakamaki H, Honda K, Ohashi K. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol 2017;96:1517-23. [PMID: 28733895 DOI: 10.1007/s00277-017-3069-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
14 Haring E, Zeiser R, Apostolova P. Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease. Front Immunol 2021;12:705342. [PMID: 34249014 DOI: 10.3389/fimmu.2021.705342] [Reference Citation Analysis]
15 Servais S, Beguin Y, Delens L, Ehx G, Fransolet G, Hannon M, Willems E, Humblet-Baron S, Belle L, Baron F. Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Expert Opin Investig Drugs 2016;25:957-72. [PMID: 27110922 DOI: 10.1080/13543784.2016.1182498] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
16 Zhao XS, Huang XJ. Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? Biomark Res 2019;7:17. [PMID: 31406575 DOI: 10.1186/s40364-019-0167-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
18 Ghimire S, Weber D, Hippe K, Meedt E, Hoepting M, Kattner AS, Hiergeist A, Gessner A, Matos C, Ghimire S, Wolff D, Edinger M, Hoffmann P, Poeck H, Herr W, Holler E. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics. Front Immunol 2021;12:753287. [PMID: 34777363 DOI: 10.3389/fimmu.2021.753287] [Reference Citation Analysis]
19 Heidrich V, Bruno JS, Knebel FH, de Molla VC, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Fregnani ER, Camargo AA. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:692225. [PMID: 34220852 DOI: 10.3389/fimmu.2021.692225] [Reference Citation Analysis]
20 Meedt E, Hiergeist A, Gessner A, Dettmer K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Weber D. Prolonged suppression of butyrate producing bacteria is associated with acute gastrointestinal graft-versus-host disease and transplant related mortality after allogeneic stem cell transplantation. Clin Infect Dis 2021:ciab500. [PMID: 34043764 DOI: 10.1093/cid/ciab500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Stämmler F, Gläsner J, Hiergeist A, Holler E, Weber D, Oefner PJ, Gessner A, Spang R. Adjusting microbiome profiles for differences in microbial load by spike-in bacteria. Microbiome 2016;4:28. [PMID: 27329048 DOI: 10.1186/s40168-016-0175-0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 86] [Article Influence: 17.5] [Reference Citation Analysis]
22 Fredricks DN. The gut microbiota and graft-versus-host disease. J Clin Invest 2019;129:1808-17. [PMID: 31042160 DOI: 10.1172/JCI125797] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 11.3] [Reference Citation Analysis]
23 Nucci M. How I Treat Febrile Neutropenia. Mediterr J Hematol Infect Dis 2021;13:e2021025. [PMID: 33747406 DOI: 10.4084/MJHID.2021.025] [Reference Citation Analysis]
24 Fredricks DN. The gut microbiota and graft-versus-host disease. Journal of Clinical Investigation 2019;129:1808-17. [DOI: 10.1172/jci125797] [Reference Citation Analysis]
25 Khuat LT, Dave M, Murphy WJ. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation. Gut Microbes 2021;13:1966262. [PMID: 34455917 DOI: 10.1080/19490976.2021.1966262] [Reference Citation Analysis]
26 Benamu E, Deresinski S. Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention. F1000Res 2018;7:3. [PMID: 29333263 DOI: 10.12688/f1000research.11831.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Gaines BR, Kim J, Zhou H. Algorithms for Fitting the Constrained Lasso. J Comput Graph Stat 2018;27:861-71. [PMID: 30618485 DOI: 10.1080/10618600.2018.1473777] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
28 Bonvalet M, Daillère R, Roberti MP, Rauber C, Zitvogel L. The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer. In: Zitvogel L, Kroemer G, editors. Oncoimmunology. Cham: Springer International Publishing; 2018. pp. 447-62. [DOI: 10.1007/978-3-319-62431-0_27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 He FC, Holtan SG. Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions. Curr Hematol Malig Rep 2018;13:44-52. [DOI: 10.1007/s11899-018-0433-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
30 Teshima T, Reddy P, Zeiser R. Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:S3-8. [PMID: 26899274 DOI: 10.1016/j.bbmt.2016.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
31 Yoshioka K, Kakihana K, Doki N, Ohashi K. Gut microbiota and acute graft-versus-host disease. Pharmacol Res 2017;122:90-5. [PMID: 28576475 DOI: 10.1016/j.phrs.2017.05.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
32 Ramalingam S, Siamakpour-Reihani S, Bohannan L, Ren Y, Sibley A, Sheng J, Ma L, Nixon AB, Lyu J, Parker DC, Bain J, Muehlbauer M, Ilkayeva O, Kraus VB, Huebner JL, Spitzer T, Brown J, Peled JU, van den Brink M, Gomes A, Choi T, Gasparetto C, Horwitz M, Long G, Lopez R, Rizzieri D, Sarantopoulos S, Chao N, Sung AD. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant. PLoS One 2021;16:e0252995. [PMID: 34170918 DOI: 10.1371/journal.pone.0252995] [Reference Citation Analysis]
33 De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro-Mejía JL, Nielsen DS, Nersting J, Wehner PS, Schmiegelow K, Hasle H, Pamp SJ, Müller K. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota. Int J Cancer 2020;147:1953-62. [PMID: 32115690 DOI: 10.1002/ijc.32942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
34 Chen S, Zeiser R. Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:1854. [PMID: 33013836 DOI: 10.3389/fimmu.2020.01854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lind ML, Mooney SJ, Carone M, Althouse BM, Liu C, Evans LE, Patel K, Vo PT, Pergam SA, Phipps AI. Development and Validation of a Machine Learning Model to Estimate Bacterial Sepsis Among Immunocompromised Recipients of Stem Cell Transplant. JAMA Netw Open 2021;4:e214514. [PMID: 33871619 DOI: 10.1001/jamanetworkopen.2021.4514] [Reference Citation Analysis]
36 Golob JL, DeMeules MM, Loeffelholz T, Quinn ZZ, Dame MK, Silvestri SS, Wu MC, Schmidt TM, Fiedler TL, Hoostal MJ, Mielcarek M, Spence J, Pergam SA, Fredricks DN. Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD. Blood Adv 2019;3:2866-9. [PMID: 31585950 DOI: 10.1182/bloodadvances.2019000362] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
37 Lyu MN, Han MZ. [Advances in intestinal microbiota and graft versus host disease]. Zhonghua Xue Ye Xue Za Zhi 2017;38:1085-8. [PMID: 29365409 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.019] [Reference Citation Analysis]
38 Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol 2018;97:509-17. [PMID: 29255911 DOI: 10.1007/s00277-017-3205-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
39 Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA. Mycobiota in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 2015;12:77-87. [PMID: 25385227 DOI: 10.1038/nrgastro.2014.188] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 12.1] [Reference Citation Analysis]
40 Yu J, Sun H, Cao W, Han L, Song Y, Wan D, Jiang Z. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Exp Hematol Oncol 2020;9:35. [PMID: 33292670 DOI: 10.1186/s40164-020-00194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, Brunnberg U, Brandts C, Ballo O, von Metzler I, Kessel J, Serve H, Steffen B. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study. Biol Blood Marrow Transplant 2017;23:1455-62. [PMID: 28528711 DOI: 10.1016/j.bbmt.2017.05.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
42 Jenq RR. How's your microbiota? Let's check your urine. Blood 2015;126:1641-2. [PMID: 26429966 DOI: 10.1182/blood-2015-08-661504] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
43 Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015;101:428-37. [PMID: 25812838 DOI: 10.1007/s12185-015-1781-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
44 van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, Heubel-Moenen FCJI, Nur E, Zeerleder SS, Nieuwdorp M, Blom B, Hazenberg MD. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med 2020;12:eaaz8926. [PMID: 32801142 DOI: 10.1126/scitranslmed.aaz8926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
45 Yoshifuji K, Inamoto K, Kiridoshi Y, Takeshita K, Sasajima S, Shiraishi Y, Yamashita Y, Nisaka Y, Ogura Y, Takeuchi R, Toya T, Igarashi A, Najima Y, Doki N, Kobayashi T, Ohashi K, Suda W, Atarashi K, Shiota A, Hattori M, Honda K, Kakihana K. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv 2020;4:4607-17. [PMID: 32991720 DOI: 10.1182/bloodadvances.2020002604] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
46 Carson TL, Little RB, Townsend S. Preliminary feasibility for recruiting and retaining black and white females to provide fecal samples for longitudinal research. Gut Pathog 2019;11:43. [PMID: 31462930 DOI: 10.1186/s13099-019-0324-7] [Reference Citation Analysis]
47 Li X, Lin Y, Li X, Xu X, Zhao Y, Xu L, Gao Y, Li Y, Tan Y, Qian P, Huang H. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome. EBioMedicine 2020;61:103048. [PMID: 33039712 DOI: 10.1016/j.ebiom.2020.103048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Abedin S, Hamadani M. Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease. J Exp Pharmacol 2020;12:549-57. [PMID: 33273867 DOI: 10.2147/JEP.S259290] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Raghunathan VM, Sheng I, Lim SH. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. J Transl Med 2016;14:335. [PMID: 27912759 DOI: 10.1186/s12967-016-1094-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33:570-580. [PMID: 29634945 DOI: 10.1016/j.ccell.2018.03.015] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 123.7] [Reference Citation Analysis]
51 Griesenauer B, Jiang H, Yang J, Zhang J, Ramadan AM, Egbosiuba J, Campa K, Paczesny S. ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells. J Immunol 2019;202:3053-64. [PMID: 30979817 DOI: 10.4049/jimmunol.1800447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Docampo MD, Auletta JJ, Jenq RR. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow. Biol Blood Marrow Transplant 2015;21:1360-6. [PMID: 25708215 DOI: 10.1016/j.bbmt.2015.02.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
53 Bossù G, Di Sario R, Argentiero A, Esposito S. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer. Antibiotics (Basel) 2021;10:152. [PMID: 33546312 DOI: 10.3390/antibiotics10020152] [Reference Citation Analysis]
54 Müskens KF, Lindemans CA, Belderbos ME. Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process? Cells 2021;10:2051. [PMID: 34440819 DOI: 10.3390/cells10082051] [Reference Citation Analysis]
55 Noor F, Kaysen A, Wilmes P, Schneider JG. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials. J Innate Immun 2019;11:405-15. [PMID: 30286447 DOI: 10.1159/000492943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
56 Schwabkey ZI, Jenq RR. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. Annu Rev Med 2020;71:137-48. [PMID: 31986084 DOI: 10.1146/annurev-med-052918-122440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 Toro JF, Peña E, Ramírez O, López P, Portilla CA, López-Medina E. Routine Use of Biomarkers to Rationalize Antibiotic Use During Febrile Episodes in Pediatric Bone Marrow Transplantation Units. Pediatr Infect Dis J 2021;40:1023-8. [PMID: 34636797 DOI: 10.1097/INF.0000000000003239] [Reference Citation Analysis]
58 Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, Dettmer K, Weber M, Wolff D, Hahn J, Pamer EG, Herr W, Gessner A, Oefner PJ, van den Brink MRM, Holler E. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 2017;23:845-52. [PMID: 28232086 DOI: 10.1016/j.bbmt.2017.02.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 23.6] [Reference Citation Analysis]
59 Mancini N, Greco R, Pasciuta R, Barbanti MC, Pini G, Morrow OB, Morelli M, Vago L, Clementi N, Giglio F, Lupo Stanghellini MT, Forcina A, Infurnari L, Marktel S, Assanelli A, Carrabba M, Bernardi M, Corti C, Burioni R, Peccatori J, Sormani MP, Banfi G, Ciceri F, Clementi M. Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients. Open Forum Infect Dis 2017;4:ofx215. [PMID: 29226172 DOI: 10.1093/ofid/ofx215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
60 Biliński J, Jasiński M, Basak GW. The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease. Biomedicines 2022;10:837. [DOI: 10.3390/biomedicines10040837] [Reference Citation Analysis]
61 Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol 2016;173:190-205. [PMID: 27019012 DOI: 10.1111/bjh.13959] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
62 Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transpl Infect Dis 2015;17:702-6. [PMID: 26198302 DOI: 10.1111/tid.12423] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
63 Kumari R, Palaniyandi S, Hildebrandt GC. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease. Dig Dis Sci 2019;64:669-77. [PMID: 30523482 DOI: 10.1007/s10620-018-5369-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
64 Lähteenmäki K, Wacklin P, Taskinen M, Tuovinen E, Lohi O, Partanen J, Mättö J, Vettenranta K. Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients. Bone Marrow Transplant 2017;52:1479-82. [PMID: 28783141 DOI: 10.1038/bmt.2017.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation. Clin Transplant 2018;32:e13361. [PMID: 30054935 DOI: 10.1111/ctr.13361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
67 Spindelboeck W, Schulz E, Uhl B, Kashofer K, Aigelsreiter A, Zinke-Cerwenka W, Mulabecirovic A, Kump PK, Halwachs B, Gorkiewicz G, Sill H, Greinix H, Högenauer C, Neumeister P. Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica 2017;102:e210-3. [PMID: 28154090 DOI: 10.3324/haematol.2016.154351] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
68 Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21(3): 803-814 [PMID: 25624713 DOI: 10.3748/wjg.v21.i3.803] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 127] [Article Influence: 24.9] [Reference Citation Analysis]
69 Hülsdünker J, Thomas OS, Haring E, Unger S, Gonzalo Núñez N, Tugues S, Gao Z, Duquesne S, Cywes-Bentley C, Oyardi O, Kirschnek S, Schmitt-Graeff A, Pabst O, Koenecke C, Duyster J, Apostolova P, Blaser MJ, Becher B, Pier GB, Häcker G, Zeiser R. Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity. Proc Natl Acad Sci U S A 2019;116:20700-6. [PMID: 31527267 DOI: 10.1073/pnas.1908549116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
70 Bertolini M, Dongari-Bagtzoglou A. The Relationship of Candida albicans with the Oral Bacterial Microbiome in Health and Disease. Adv Exp Med Biol 2019;1197:69-78. [PMID: 31732935 DOI: 10.1007/978-3-030-28524-1_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
71 Kornblit B, Müller K. Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:499-505. [PMID: 27941769 DOI: 10.1038/bmt.2016.263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
72 Renteria AS, Levine JE, Ferrara JLM. Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease. Expert Opin Orphan Drugs 2016;4:469-84. [PMID: 30057862 DOI: 10.1517/21678707.2016.1166949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Jordan K, Pontoppidan P, Uhlving HH, Kielsen K, Burrin DG, Weischendorff S, Christensen IJ, Jørgensen MH, Heilmann C, Sengeløv H, Müller K. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2017;23:1170-6. [DOI: 10.1016/j.bbmt.2017.03.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
74 Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y. Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1028-33. [DOI: 10.1016/j.bbmt.2020.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
75 Riwes M, Reddy P. Microbes and Their Metabolites Correlate with Hematopoietic Stem Cell Transplantation Outcomes? Biol Blood Marrow Transplant 2018;24:e7-8. [PMID: 30439543 DOI: 10.1016/j.bbmt.2018.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO. Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial. Sci Rep 2021;11:11593. [PMID: 34078971 DOI: 10.1038/s41598-021-90976-z] [Reference Citation Analysis]
77 Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ. Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transplant 2017;52:1091-106. [PMID: 28346417 DOI: 10.1038/bmt.2017.14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
78 Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nat Med 2022;28:690-703. [PMID: 35440726 DOI: 10.1038/s41591-022-01779-2] [Reference Citation Analysis]
79 de Molla VC, Heidrich V, Bruno JS, Knebel FH, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Camargo AA, Fregnani ER, Arrais-Rodrigues C. Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation. Sci Rep 2021;11:17552. [PMID: 34475459 DOI: 10.1038/s41598-021-96939-8] [Reference Citation Analysis]
80 Hippen KL, Aguilar EG, Rhee SY, Bolivar-Wagers S, Blazar BR. Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease. Trends Immunol 2020;41:77-91. [PMID: 31791718 DOI: 10.1016/j.it.2019.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
81 Zheng HB, Yeung C, Summers C, Lee D, Wahbeh G, Braly K, Suskind D. Dietary Therapy in Conjunction With Immunosuppression to Treat Gastrointestinal Graft-versus-host Disease (GVHD). J Pediatr Gastroenterol Nutr 2019;69:e20-2. [PMID: 30676523 DOI: 10.1097/MPG.0000000000002288] [Reference Citation Analysis]
82 Bouazzaoui A, Huber E, Dan A, Al-Allaf FA, Pfirstinger J, Sprotte G, Köstler J, Hiergeist A, Gessner A, Herr W, Holler E. Reduction of aGVHD using chicken antibodies directed against intestinal pathogens in a murine model. Blood 2017;129:1052-5. [PMID: 28011676 DOI: 10.1182/blood-2016-06-722538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
83 Fishman JA, Thomson AW. Clinical Implications of Basic Science Discoveries: Immune Homeostasis and the Microbiome-Dietary and Therapeutic Modulation and Implications for Transplantation: Immune Homeostasis and the Microbiome. American Journal of Transplantation 2015;15:1755-8. [DOI: 10.1111/ajt.13236] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
84 El-jurdi N, de Lima M, Lazarus H, Ghannoum MA. Microbiome: Its Impact Is Being Revealed! Curr Clin Micro Rpt 2017;4:78-87. [DOI: 10.1007/s40588-017-0063-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Aggarwal N, Deerhake ME, Dipalma D, Shahi SK, Gaggioli MR, Mangalam AK, Shinohara ML. Secreted osteopontin from CD4+ T cells limits acute graft-versus-host disease. Cell Reports 2021;37:110170. [DOI: 10.1016/j.celrep.2021.110170] [Reference Citation Analysis]
86 Hayase E, Hashimoto D, Nakamura K, Noizat C, Ogasawara R, Takahashi S, Ohigashi H, Yokoi Y, Sugimoto R, Matsuoka S, Ara T, Yokoyama E, Yamakawa T, Ebata K, Kondo T, Hiramine R, Aizawa T, Ogura Y, Hayashi T, Mori H, Kurokawa K, Tomizuka K, Ayabe T, Teshima T. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. J Exp Med 2017;214:3507-18. [PMID: 29066578 DOI: 10.1084/jem.20170418] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
87 Han L, Jin H, Zhou L, Zhang X, Fan Z, Dai M, Lin Q, Huang F, Xuan L, Zhang H, Liu Q. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients. Front Immunol 2018;9:669. [PMID: 29740427 DOI: 10.3389/fimmu.2018.00669] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
88 Zeiser R, Socié G, Blazar BR. Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation. Br J Haematol 2016;175:191-207. [PMID: 27619472 DOI: 10.1111/bjh.14295] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 11.2] [Reference Citation Analysis]
89 Ogimi C, Krantz EM, Golob JL, Waghmare A, Liu C, Leisenring WM, Woodard CR, Marquis S, Kuypers JM, Jerome KR, Pergam SA, Fredricks DN, Sorror ML, Englund JA, Boeckh M. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2293-301. [PMID: 29777867 DOI: 10.1016/j.bbmt.2018.05.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
90 Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv 2020;4:5797-809. [PMID: 33232475 DOI: 10.1182/bloodadvances.2020002677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
91 Zama D, Biagi E, Masetti R, Gasperini P, Prete A, Candela M, Brigidi P, Pession A. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant 2017;52:7-14. [PMID: 27348539 DOI: 10.1038/bmt.2016.173] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
92 Winichakoon P, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Impact of gut microbiota on kidney transplantation. Transplant Rev (Orlando) 2021;36:100668. [PMID: 34688985 DOI: 10.1016/j.trre.2021.100668] [Reference Citation Analysis]
93 Li W, Deng X, Chen T. Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy. Front Oncol 2021;11:644454. [PMID: 33928033 DOI: 10.3389/fonc.2021.644454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Bowerman KL, Varelias A, Lachner N, Kuns RD, Hill GR, Hugenholtz P. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice. Gut Microbes 2020;11:754-70. [PMID: 31928131 DOI: 10.1080/19490976.2019.1705729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
95 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Rashidi A, Shanley R, Holtan SG, MacMillan ML, Blazar BR, Khoruts A, Weisdorf DJ. Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 2018;24:2190-6. [PMID: 30454871 DOI: 10.1016/j.bbmt.2018.06.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
97 Érsek B, Lupsa N, Pócza P, Tóth A, Horváth A, Molnár V, Bagita B, Bencsik A, Hegyesi H, Matolcsy A, Buzás EI, Pós Z. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease. Cell Mol Life Sci 2016;73:3935-47. [PMID: 27137185 DOI: 10.1007/s00018-016-2237-7] [Reference Citation Analysis]
98 Libiger O, Schork NJ. Partial Least Squares Regression Can Aid in Detecting Differential Abundance of Multiple Features in Sets of Metagenomic Samples. Front Genet 2015;6:350. [PMID: 26734061 DOI: 10.3389/fgene.2015.00350] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Taur Y. Intestinal microbiome changes and stem cell transplantation: Lessons learned. Virulence. 2016;7:930-938. [PMID: 27805463 DOI: 10.1080/21505594.2016.1250982] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
100 Vindigni SM, Surawicz CM. The gut microbiome: a clinically significant player in transplantation? Expert Rev Clin Immunol. 2015;11:781-783. [PMID: 26065325 DOI: 10.1586/1744666x.2015.1043894] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
101 Crossland RE, Perutelli F, Bogunia-Kubik K, Mooney N, Milutin Gašperov N, Pučić-Baković M, Greinix H, Weber D, Holler E, Pulanić D, Wolff D, Dickinson AM, Inngjerdingen M, Grce M. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease. Front Immunol 2020;11:602547. [PMID: 33424849 DOI: 10.3389/fimmu.2020.602547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
102 Maurer AK, Li S, Hunter BD, Luk SO, O'Donnell SE, Dey BR, El-Jawahri A, Frigault MJ, McAfee S, O'Donnell PV, Spitzer TR, Chen YB, DeFilipp Z. Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2020;55:2319-21. [PMID: 32457426 DOI: 10.1038/s41409-020-0923-4] [Reference Citation Analysis]
103 Kuba A, Raida L. Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. Mediators Inflamm 2018;2018:9451950. [PMID: 29785172 DOI: 10.1155/2018/9451950] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
104 Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury. Int Urol Nephrol 2019;51:293-302. [PMID: 30604232 DOI: 10.1007/s11255-018-2056-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
105 Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, Pinedo R, Tsakmaklis A, Littmann ER, Pastore A, Taur Y, Monette S, Arcila ME, Pickard AJ, Maloy M, Wright RJ, Amoretti LA, Fontana E, Pham D, Jamal MA, Weber D, Sung AD, Hashimoto D, Scheid C, Xavier JB, Messina JA, Romero K, Lew M, Bush A, Bohannon L, Hayasaka K, Hasegawa Y, Vehreschild MJGT, Cross JR, Ponce DM, Perales MA, Giralt SA, Jenq RR, Teshima T, Holler E, Chao NJ, Pamer EG, Peled JU, van den Brink MRM. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 2019;366:1143-9. [PMID: 31780560 DOI: 10.1126/science.aax3760] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 39.0] [Reference Citation Analysis]
106 Kaito S, Toya T, Yoshifuji K, Kurosawa S, Inamoto K, Takeshita K, Suda W, Kakihana K, Honda K, Hattori M, Ohashi K. Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease. Blood Adv 2018;2:3097-101. [PMID: 30446486 DOI: 10.1182/bloodadvances.2018024968] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
107 Payen M, Nicolis I, Robin M, Michonneau D, Delannoye J, Mayeur C, Kapel N, Berçot B, Butel MJ, Le Goff J, Socié G, Rousseau C. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Adv 2020;4:1824-32. [PMID: 32353108 DOI: 10.1182/bloodadvances.2020001531] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
108 Oldenburg M, Rüchel N, Janssen S, Borkhardt A, Gössling KL. The Microbiome in Childhood Acute Lymphoblastic Leukemia. Cancers (Basel) 2021;13:4947. [PMID: 34638430 DOI: 10.3390/cancers13194947] [Reference Citation Analysis]
109 Plantinga AM, Chen J, Jenq RR, Wu MC. pldist: ecological dissimilarities for paired and longitudinal microbiome association analysis. Bioinformatics 2019;35:3567-75. [PMID: 30863868 DOI: 10.1093/bioinformatics/btz120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
110 Ramakrishna C, Mendonca S, Ruegger PM, Kim JH, Borneman J, Cantin EM. Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis. PLoS One 2020;15:e0237189. [PMID: 32760124 DOI: 10.1371/journal.pone.0237189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Saqr A, Carlson B, Staley C, Rashidi A, Al-Kofahi M, Kaiser T, Holtan S, MacMillan M, Young JA, Jurdi NE, Weisdorf D, Khoruts A, Jacobson PA. Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation. Transplant Cell Ther 2022:S2666-6367(22)01241-6. [PMID: 35489611 DOI: 10.1016/j.jtct.2022.04.018] [Reference Citation Analysis]
112 Scheich S, Weber S, König R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, Hogardt M, A J Kempf V, Kessel J, Martin H, Bug G, Serve H, Steffen B. Timepoints of vancomycin-resistant Enterococcus colonization predict outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation. Eur J Haematol 2018. [PMID: 30048011 DOI: 10.1111/ejh.13151] [Reference Citation Analysis]
113 Galloway-Peña JR, Jenq RR, Shelburne SA. Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient? Clin Cancer Res 2017;23:3263-8. [PMID: 28298544 DOI: 10.1158/1078-0432.CCR-16-3173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
114 Ciernikova S, Kasperova B, Drgona L, Smolkova B, Stevurkova V, Mego M. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation. Blood Rev 2021;48:100790. [PMID: 33573867 DOI: 10.1016/j.blre.2020.100790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC, Graf N, Simon A, Franke K, Bittenbring J, Wilmes P, Schneider JG. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. Transl Res 2017;186:79-94.e1. [PMID: 28686852 DOI: 10.1016/j.trsl.2017.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
116 Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, Besier S, Kempf VAJ, Kessel J, Martin H, Wilke AC, Serve H, Bug G, Steffen B. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Cancer 2018;124:286-96. [PMID: 28960264 DOI: 10.1002/cncr.31045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
117 Altenbuchinger M, Rehberg T, Zacharias HU, Stämmler F, Dettmer K, Weber D, Hiergeist A, Gessner A, Holler E, Oefner PJ, Spang R. Reference point insensitive molecular data analysis. Bioinformatics 2017;33:219-26. [PMID: 27634945 DOI: 10.1093/bioinformatics/btw598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
118 Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med 2018;10:eaap9489. [PMID: 30257956 DOI: 10.1126/scitranslmed.aap9489] [Cited by in Crossref: 138] [Cited by in F6Publishing: 128] [Article Influence: 46.0] [Reference Citation Analysis]
119 Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ. Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. Br J Haematol 2018;182:887-94. [PMID: 30004111 DOI: 10.1111/bjh.15492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
120 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
121 Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, Núñez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun 2018;9:3674. [PMID: 30201970 DOI: 10.1038/s41467-018-06048-w] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
122 Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol 2020;188:438-49. [PMID: 31566729 DOI: 10.1111/bjh.16205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
123 Gorkiewicz G, Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Archiv : an international journal of pathology. 2018;472:159-172. [PMID: 29243124 DOI: 10.1007/s00428-017-2277-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
124 Norona J, Apostolova P, Schmidt D, Ihlemann R, Reischmann N, Taylor G, Köhler N, de Heer J, Heeg S, Andrieux G, Siranosian BA, Schmitt-Graeff A, Pfeifer D, Catalano A, Frew IJ, Proietti M, Grimbacher B, Bulashevska A, Bhatt AS, Brummer T, Clauditz T, Zabelina T, Kroeger N, Blazar BR, Boerries M, Ayuk F, Zeiser R. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. Blood 2020;136:1442-55. [PMID: 32542357 DOI: 10.1182/blood.2020005957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
125 Köhler N, Zeiser R. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Front Immunol 2018;9:3179. [PMID: 30705680 DOI: 10.3389/fimmu.2018.03179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
126 Spindelboeck W, Halwachs B, Bayer N, Huber-Krassnitzer B, Schulz E, Uhl B, Gaksch L, Hatzl S, Bachmayr V, Kleissl L, Kump P, Deutsch A, Stary G, Greinix H, Gorkiewicz G, Högenauer C, Neumeister P. Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study. Ther Adv Hematol 2021;12:20406207211058333. [PMID: 34987741 DOI: 10.1177/20406207211058333] [Reference Citation Analysis]
127 Lee SE, Lim JY, Ryu DB, Kim TW, Park SS, Jeon YW, Yoon JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Kim CS, Shin DM, Min CK. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant 2019;25:1933-43. [PMID: 31195137 DOI: 10.1016/j.bbmt.2019.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
128 Malard F, Lavelle A, Battipaglia G, Gaugler B, Dulery R, Brissot E, Mediavilla C, Jegou S, Rolhion N, Ledraa T, Mohty R, Sokol H, Mohty M. Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation. Mucosal Immunol 2021;14:1127-32. [PMID: 34282272 DOI: 10.1038/s41385-021-00429-z] [Reference Citation Analysis]
129 Weber D, Frauenschläger K, Ghimire S, Peter K, Panzer I, Hiergeist A, Weber M, Kutny D, Wolff D, Grube M, Huber E, Oefner P, Gessner A, Hehlgans T, Herr W, Holler E. The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation. PLoS One 2017;12:e0185265. [PMID: 28934349 DOI: 10.1371/journal.pone.0185265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
130 Haring E, Uhl FM, Andrieux G, Proietti M, Bulashevska A, Sauer B, Braun LM, de Vega Gomez E, Esser PR, Martin SF, Pfeifer D, Follo M, Schmitt-Graeff A, Buescher J, Duyster J, Grimbacher B, Boerries M, Pearce EL, Zeiser R, Apostolova P. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect. Haematologica 2021;106:2131-46. [PMID: 32675222 DOI: 10.3324/haematol.2019.242990] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
131 Gea-Banacloche J, Komanduri KV, Carpenter P, Paczesny S, Sarantopoulos S, Young JA, El Kassar N, Le RQ, Schultz KR, Griffith LM, Savani BN, Wingard JR. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biol Blood Marrow Transplant 2017;23:870-81. [PMID: 27751936 DOI: 10.1016/j.bbmt.2016.10.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
132 Kanangat S, Skaljic I. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing. Hum Immunol 2021:S0198-8859(21)00183-X. [PMID: 34364710 DOI: 10.1016/j.humimm.2021.07.009] [Reference Citation Analysis]
133 Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, Mimura I, Morita H, Sugiyama D, Nishikawa H, Hattori M, Hino Y, Ikegawa S, Yamamoto K, Toya T, Doki N, Koizumi K, Honda K, Ohashi K. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood 2016;128:2083-8. [PMID: 27461930 DOI: 10.1182/blood-2016-05-717652] [Cited by in Crossref: 163] [Cited by in F6Publishing: 163] [Article Influence: 27.2] [Reference Citation Analysis]
134 Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, Sauter CS, Landau HJ, Dahi PB, Perales MA, Chung DJ, Lesokhin AM, Dai A, Clurman A, Slingerland JB, Slingerland AE, Brereton DG, Giardina PA, Maloy M, Armijo GK, Rondon-Clavo C, Fontana E, Bohannon L, Ramalingam S, Bush AT, Lew MV, Messina JA, Littmann E, Taur Y, Jenq RR, Chao NJ, Giralt S, Markey KA, Pamer EG, van den Brink MRM, Peled JU. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood 2021;137:1527-37. [PMID: 33512409 DOI: 10.1182/blood.2020006923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
135 Shang T, Guo Y, Li X, Zhou Z, Qi Y, Salahdiin K, Shen R, He S, Wang M, Shi Z, Zhao X, Yang J, Fan G, Wang Y, Gao X, Zhu Y, Feng Y. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment. Biomedicine & Pharmacotherapy 2022;148:112675. [DOI: 10.1016/j.biopha.2022.112675] [Reference Citation Analysis]
136 Singh RP, Bashir H, Kumar R. Emerging role of microbiota in immunomodulation and cancer immunotherapy. Semin Cancer Biol 2021;70:37-52. [PMID: 32580024 DOI: 10.1016/j.semcancer.2020.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Tabibian JH, Kenderian SS. The Microbiome and Immune Regulation After Transplantation. Transplantation 2017;101:56-62. [PMID: 27517729 DOI: 10.1097/TP.0000000000001444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
138 Song Q, Nasri U, Zeng D. Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model. Front Immunol 2022;13:844271. [DOI: 10.3389/fimmu.2022.844271] [Reference Citation Analysis]
139 Lane JP, Stewart CJ, Cummings SP, Gennery AR. Functional changes in gut microbiota during hematopoietic stem cell transplantation for severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2016;138:622-625.e3. [DOI: 10.1016/j.jaci.2016.02.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Magenau J, Reddy P. Next generation treatment of acute graft-versus-host disease. Leukemia 2014;28:2283-91. [PMID: 24938648 DOI: 10.1038/leu.2014.195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
141 Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J. Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study. Transplant Cell Ther 2021:S2666-6367(21)01300-2. [PMID: 34656808 DOI: 10.1016/j.jtct.2021.10.008] [Reference Citation Analysis]
142 Zhang F, Zuo T, Yeoh YK, Cheng FWT, Liu Q, Tang W, Cheung KCY, Yang K, Cheung CP, Mo CC, Hui M, Chan FKL, Li CK, Chan PKS, Ng SC. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nat Commun 2021;12:65. [PMID: 33397897 DOI: 10.1038/s41467-020-20240-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
143 El Jurdi N, Filali-mouhim A, Salem I, Retuerto M, Dambrosio NM, Baer L, Lazarus HM, Caimi P, Cooper B, Tomlinson B, Metheny L, Malek E, Otegbeye F, Sekaly R, Ghannoum M, de Lima M. Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study. Biology of Blood and Marrow Transplantation 2019;25:1511-9. [DOI: 10.1016/j.bbmt.2019.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
144 Carpenter PA. Vitamin A to reduce gut leak and GVHD? Blood 2017;129:2715-7. [PMID: 28522464 DOI: 10.1182/blood-2017-03-773226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
145 Belasen AM, Riolo MA, Bletz MC, Lyra ML, Toledo LF, James TY. Geography, Host Genetics, and Cross-Domain Microbial Networks Structure the Skin Microbiota of Fragmented Brazilian Atlantic Forest Frog Populations. Ecol Evol 2021;11:9293-307. [PMID: 34306622 DOI: 10.1002/ece3.7594] [Reference Citation Analysis]
146 Dougé A, Bay JO, Ravinet A, Scanzi J. [Intestinal microbiota and allogeneic stem cell transplantation]. Bull Cancer 2020;107:72-83. [PMID: 31582175 DOI: 10.1016/j.bulcan.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
147 Innao V, Allegra AG, Musolino C, Allegra A. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era. Int J Mol Sci 2020;21:E8902. [PMID: 33255336 DOI: 10.3390/ijms21238902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
148 Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G. B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2016;7:660. [PMID: 28138325 DOI: 10.3389/fimmu.2016.00660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
149 Golob JL, Pergam SA, Srinivasan S, Fiedler TL, Liu C, Garcia K, Mielcarek M, Ko D, Aker S, Marquis S, Loeffelholz T, Plantinga A, Wu MC, Celustka K, Morrison A, Woodfield M, Fredricks DN. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation. Clin Infect Dis 2017;65:1984-91. [PMID: 29020185 DOI: 10.1093/cid/cix699] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 18.8] [Reference Citation Analysis]
150 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
151 Brevi A, Cogrossi LL, Lorenzoni M, Mattorre B, Bellone M. The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma. Front Immunol 2022;13:845422. [DOI: 10.3389/fimmu.2022.845422] [Reference Citation Analysis]
152 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood. 2016;128:2395-2402. [PMID: 27856471 DOI: 10.1182/blood-2016-06-716738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
153 Nicholson MR, Osgood CL, Acra SA, Edwards KM. Clostridium difficile infection in the pediatric transplant patient. Pediatr Transplant 2015;19:792-8. [PMID: 26403484 DOI: 10.1111/petr.12578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
154 Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Julamanee J, Takagi E, Hirano D, Miyao K, Sakemura R, Goto T, Hayakawa F, Seto A, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H. High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype. PLoS One 2017;12:e0185213. [PMID: 28945764 DOI: 10.1371/journal.pone.0185213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
155 Koh AY. The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection. PLoS Pathog 2017;13:e1006342. [PMID: 28662165 DOI: 10.1371/journal.ppat.1006342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
156 Chen Y, Zhao Y, Cheng Q, Wu D, Liu H. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease. J Immunol Res 2015;2015:145859. [PMID: 26090477 DOI: 10.1155/2015/145859] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
157 Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis 2019;6:ofz173. [PMID: 31065565 DOI: 10.1093/ofid/ofz173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
158 Liu C, Frank DN, Horch M, Chau S, Ir D, Horch EA, Tretina K, van Besien K, Lozupone CA, Nguyen VH. Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone Marrow Transplant 2017;52:1643-50. [PMID: 28967895 DOI: 10.1038/bmt.2017.200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
159 Clavel T, Lagkouvardos I, Hiergeist A. Microbiome sequencing: challenges and opportunities for molecular medicine. Expert Review of Molecular Diagnostics 2016;16:795-805. [DOI: 10.1080/14737159.2016.1184574] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
160 Ara T, Hashimoto D. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage. Front Immunol 2021;12:713631. [PMID: 34512636 DOI: 10.3389/fimmu.2021.713631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 D'Amico F, Soverini M, Zama D, Consolandi C, Severgnini M, Prete A, Pession A, Barone M, Turroni S, Biagi E, Brigidi P, Masetti R, Rampelli S, Candela M. Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation. Sci Rep 2019;9:5649. [PMID: 30948795 DOI: 10.1038/s41598-019-42222-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
162 Kuo SZ, Dettmer K, Annavajhala MK, Chong DH, Uhlemann AC, Abrams JA, Oefner PJ, Freedberg DE. Associations between urinary 3-indoxyl sulfate, a gut microbiome-derived biomarker, and patient outcomes after intensive care unit admission. J Crit Care 2021;63:15-21. [PMID: 33549909 DOI: 10.1016/j.jcrc.2021.01.005] [Reference Citation Analysis]
163 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Abu-Sbeih H, Ali FS, Wang Y. Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients. Curr Gastroenterol Rep 2019;21:8. [PMID: 30815766 DOI: 10.1007/s11894-019-0677-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
165 Fiorenza S, Turtle CJ. Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. Immunometabolism 2021;3:e210004. [PMID: 33552594 DOI: 10.20900/immunometab20210004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
166 Ingham AC, Kielsen K, Cilieborg MS, Lund O, Holmes S, Aarestrup FM, Müller KG, Pamp SJ. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome 2019;7:131. [PMID: 31519210 DOI: 10.1186/s40168-019-0745-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
167 Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood 2020;136:429-40. [PMID: 32526035 DOI: 10.1182/blood.2019000953] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
168 Ladas EJ, Bhatia M, Chen L, Sandler E, Petrovic A, Berman DM, Hamblin F, Gates M, Hawks R, Sung L, Nieder M. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2016;51:262-6. [PMID: 26569091 DOI: 10.1038/bmt.2015.275] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
169 Rashidi A, Khoruts A, Weisdorf DJ. Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics. Biology of Blood and Marrow Transplantation 2017;23:1038-9. [DOI: 10.1016/j.bbmt.2017.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
170 Lane JP, Stewart CJ, Cummings SP, Gennery AR. Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2015;135:1654-1656.e2. [DOI: 10.1016/j.jaci.2015.01.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
171 Ghimire S, Matos C, Caioni M, Weber D, Peter K, Holler E, Kreutz M, Renner K. Indoxyl 3-sulfate inhibits maturation and activation of human monocyte-derived dendritic cells. Immunobiology 2018;223:239-45. [PMID: 29100619 DOI: 10.1016/j.imbio.2017.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
172 Mamgain G, Patra P, Naithani M, Nath UK. The Role of Microbiota in the Development of Cancer Tumour Cells and Lymphoma of B and T Cells. Cureus 2021;13:e19047. [PMID: 34853760 DOI: 10.7759/cureus.19047] [Reference Citation Analysis]
173 Dhanya R, Agarwal RK, Ramprakash DS, Trivedi DD, Shah DV, Bhat DN, Reddy DM, Elizabeth S, Batool DA, Khalid DS, Faulkner DL. Do weekly surveillance cultures contribute to antibiotic stewardship and correlate with outcome of HSCT in children - a multicentre real-world experience of 5 years from Indian subcontinent? Transplant Cell Ther 2021:S2666-6367(21)01443-3. [PMID: 34936930 DOI: 10.1016/j.jtct.2021.12.008] [Reference Citation Analysis]
174 D'Angelo CR, Sudakaran S, Callander NS. Clinical effects and applications of the gut microbiome in hematologic malignancies. Cancer 2021;127:679-87. [PMID: 33369893 DOI: 10.1002/cncr.33400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
175 Shouval R, Geva M, Nagler A, Youngster I. Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease. Clin Hematol Int 2019;1:28-35. [PMID: 34595408 DOI: 10.2991/chi.d.190316.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
176 Kumari R, Palaniyandi S, Hildebrandt GC. The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease. Bone Marrow Transplant 2021;56:1777-83. [PMID: 34052837 DOI: 10.1038/s41409-021-01325-7] [Reference Citation Analysis]
177 de Mooij CEM, van Groningen LFJ, de Haan AFJ, Biemond BJ, Bakker M, van der Velden WJFM, Blijlevens NMA. Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)-study protocol for a multicenter randomized double-blind placebo-controlled trial. Trials 2020;21:948. [PMID: 33225965 DOI: 10.1186/s13063-020-04847-5] [Reference Citation Analysis]
178 Cameron SJ, Takáts Z. Mass spectrometry approaches to metabolic profiling of microbial communities within the human gastrointestinal tract. Methods 2018;149:13-24. [DOI: 10.1016/j.ymeth.2018.04.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
179 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
180 Staffas A, Burgos da Silva M, van den Brink MR. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood 2017;129:927-33. [PMID: 27940475 DOI: 10.1182/blood-2016-09-691394] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 15.8] [Reference Citation Analysis]
181 Ma J, Zhu W, Liu B. Role of gut microbiome in the outcome of cancer immunotherapy. Int J Cancer 2021. [PMID: 33600603 DOI: 10.1002/ijc.33524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 Andersen S, Staudacher H, Weber N, Kennedy G, Varelias A, Banks M, Bauer J. Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation. Br J Haematol 2020;188:570-81. [PMID: 31612475 DOI: 10.1111/bjh.16218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
183 Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 2018;24:1322-40. [PMID: 29471034 DOI: 10.1016/j.bbmt.2018.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
184 Shallis RM, Terry CM, Lim SH. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. Am J Hematol 2018;93:122-8. [PMID: 28842931 DOI: 10.1002/ajh.24896] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
185 Levine JE. Less (bacterial diversity) is more (deaths). Blood 2014;124:995-6. [PMID: 25124784 DOI: 10.1182/blood-2014-07-583906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
186 García-Cadenas I, Rivera I, Martino R, Esquirol A, Barba P, Novelli S, Orti G, Briones J, Brunet S, Valcarcel D, Sierra J. Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplant 2017;52:107-13. [PMID: 27595281 DOI: 10.1038/bmt.2016.225] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
187 Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016;8:339ra71. [PMID: 27194729 DOI: 10.1126/scitranslmed.aaf2311] [Cited by in Crossref: 248] [Cited by in F6Publishing: 241] [Article Influence: 49.6] [Reference Citation Analysis]
188 Ince MN, Blazar BR, Edmond MB, Tricot G, Wannemuehler MJ. Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation. Inflamm Bowel Dis 2016;22:194-201. [PMID: 26457381 DOI: 10.1097/MIB.0000000000000599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
189 Ingham AC, Kielsen K, Mordhorst H, Ifversen M, Aarestrup FM, Müller KG, Pamp SJ. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome 2021;9:148. [PMID: 34183060 DOI: 10.1186/s40168-021-01100-2] [Reference Citation Analysis]
190 Glorieux G, Tattersall J. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy. Clin Kidney J 2015;8:353-62. [PMID: 26251699 DOI: 10.1093/ckj/sfv034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
191 Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18:283-95. [PMID: 29449660 DOI: 10.1038/nrc.2018.10] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 22.0] [Reference Citation Analysis]
192 Turki AT, Bayraktar E, Basu O, Benkö T, Yi JH, Kehrmann J, Tzalavras A, Liebregts T, Beelen DW, Steckel NK. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract. Ann Hematol 2019;98:2407-19. [PMID: 31338570 DOI: 10.1007/s00277-019-03754-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Gargiullo L, Del Chierico F, D'Argenio P, Putignani L. Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives. Front Microbiol 2019;10:1704. [PMID: 31402904 DOI: 10.3389/fmicb.2019.01704] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
194 Ladas EJ, Gunter M, Huybrechts I, Barr R. A Global Strategy for Building Clinical Capacity and Advancing Research in the Context of Malnutrition and Cancer in Children within Low- and Middle-Income Countries. JNCI Monographs 2019;2019:149-51. [DOI: 10.1093/jncimonographs/lgz023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
195 Horowitz JG, Gawrys GW, Lee GC, Ramirez BA, Elledge CM, Shaughnessy PJ. Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach. Transpl Infect Dis 2021. [PMID: 34255395 DOI: 10.1111/tid.13689] [Reference Citation Analysis]
196 Kameda K, Kimura SI, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Tamaki M, Kusuda M, Akahoshi Y, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Tanihara A, Wada H, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Kanda Y. Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2019;54:707-16. [PMID: 30171223 DOI: 10.1038/s41409-018-0330-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Wardill HR, de Mooij CEM, da Silva Ferreira AR, van de Peppel IP, Havinga R, Harmsen HJM, Tissing WJE, Blijlevens NMA. Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever. Cancer Chemother Pharmacol 2021;88:173-88. [PMID: 33877390 DOI: 10.1007/s00280-021-04273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
198 Wu D, Dawson NA, Levings MK. Obesity-Associated Adipose Tissue Inflammation and Transplantation. Am J Transplant 2016;16:743-50. [PMID: 26755439 DOI: 10.1111/ajt.13578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
199 Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T. Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2302-9. [PMID: 29909153 DOI: 10.1016/j.bbmt.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
200 Tanigawa T, Watanabe T, Higashimori A, Shimada S, Kitamura H, Kuzumoto T, Nadatani Y, Otani K, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Shiba M, Suda W, Hattori M, Fujiwara Y. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota. PLoS One 2021;16:e0245995. [PMID: 33507971 DOI: 10.1371/journal.pone.0245995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Ford CD, Gazdik MA, Lopansri BK, Webb B, Mitchell B, Coombs J, Hoda D, Petersen FB. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. Biol Blood Marrow Transplant 2017;23:340-6. [PMID: 27890428 DOI: 10.1016/j.bbmt.2016.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
202 Peled JU, Jenq RR, Holler E, van den Brink MR. Role of gut flora after bone marrow transplantation. Nat Microbiol 2016;1:16036. [PMID: 27572448 DOI: 10.1038/nmicrobiol.2016.36] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
203 Teshima T, Hill GR. The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models. Front Immunol 2021;12:715424. [PMID: 34489966 DOI: 10.3389/fimmu.2021.715424] [Reference Citation Analysis]
204 Gu Z, Xiong Q, Wang L, Wang L, Li F, Hou C, Dou L, Zhu B, Liu D. The impact of intestinal microbiota in antithymocyte globulin–based myeloablative allogeneic hematopoietic cell transplantation. Cancer. [DOI: 10.1002/cncr.34091] [Reference Citation Analysis]
205 El-Jurdi N, Ghannoum MA. The Mycobiome: Impact on Health and Disease States. Microbiol Spectr 2017;5. [PMID: 28597821 DOI: 10.1128/microbiolspec.FUNK-0045-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
206 Douwes RM, Gomes-Neto AW, Eisenga MF, Van Loon E, Schutten JC, Gans ROB, Naesens M, van den Berg E, Sprangers B, Berger SP, Navis G, Blokzijl H, Meijers B, Bakker SJL, Kuypers D. The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study. PLoS Med 2020;17:e1003140. [PMID: 32542023 DOI: 10.1371/journal.pmed.1003140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med 2015;13. [DOI: 10.1186/s12967-015-0640-8] [Reference Citation Analysis]
208 Bekker V, Zwittink RD, Knetsch CW, Sanders IM, Berghuis D, Heidt PJ, Vossen JM, de Vos WM, Belzer C, Bredius RG, van‘t Hof PJ, Lankester AC, Kuijper EJ. Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2019;25:1164-71. [DOI: 10.1016/j.bbmt.2019.01.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
209 Smibert OC, Trubiano JA, Slavin MA, Kwong JC. An infectious diseases perspective on the microbiome and allogeneic stem cell transplant. Curr Opin Infect Dis 2020;33:426-32. [PMID: 33148984 DOI: 10.1097/QCO.0000000000000683] [Reference Citation Analysis]
210 Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A. The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis 2016;8:e2016025. [PMID: 27158438 DOI: 10.4084/MJHID.2016.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
211 Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson JC, Bohannon L, Martin PL, Stokhuyzen A, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Arshad M, Seed PC, Kelly MS. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2053-60. [PMID: 32682948 DOI: 10.1016/j.bbmt.2020.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
212 Murthy HS, Gharaibeh RZ, Al-Mansour Z, Kozlov A, Trikha G, Newsome RC, Gauthier J, Farhadfar N, Wang Y, Kelly DL, Lybarger J, Jobin C, Wang GP, Wingard JR. Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2001-10. [PMID: 32717434 DOI: 10.1016/j.bbmt.2020.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
213 Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant 2015;21:1373-83. [PMID: 25977230 DOI: 10.1016/j.bbmt.2015.04.016] [Cited by in Crossref: 355] [Cited by in F6Publishing: 341] [Article Influence: 50.7] [Reference Citation Analysis]
214 Zama D, Bossù G, Leardini D, Muratore E, Biagi E, Prete A, Pession A, Masetti R. Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation. Ther Adv Hematol 2020;11:2040620719896961. [PMID: 32010434 DOI: 10.1177/2040620719896961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
215 Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 2020;26:1738-46. [PMID: 32447043 DOI: 10.1016/j.bbmt.2020.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
216 Dandoy CE, Alonso PB. MBI-LCBI and CLABSI: more than scrubbing the line. Bone Marrow Transplant 2019;54:1932-9. [PMID: 30809036 DOI: 10.1038/s41409-019-0489-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
217 Sofi MH, Wu Y, Ticer T, Schutt S, Bastian D, Choi HJ, Tian L, Mealer C, Liu C, Westwater C, Armeson KE, Alekseyenko AV, Yu XZ. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight 2021;6:136841. [PMID: 33554953 DOI: 10.1172/jci.insight.136841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
218 Malard F, Gasc C, Plantamura E, Doré J. High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients. Bone Marrow Transplant 2018;53:1493-7. [PMID: 29904128 DOI: 10.1038/s41409-018-0254-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
219 Farowski F, Bücker V, Vehreschild JJ, Biehl L, Cruz-Aguilar R, Scheid C, Holtick U, Jazmati N, Wisplinghoff H, Cornely OA, Vehreschild MJGT. Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2018;53:52-7. [PMID: 29131156 DOI: 10.1038/bmt.2017.203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
220 Tyszka M, Biliński J, Basak GW. Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting. J Clin Med 2021;10:2508. [PMID: 34204044 DOI: 10.3390/jcm10112508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Tvedt THA, Skaarud KJ, Tjønnfjord GE, Gedde-Dahl T, Iversen PO, Bruserud Ø. The Systemic Metabolic Profile Early after Allogeneic Stem Cell Transplantation: Effects of Adequate Energy Support Administered through Enteral Feeding Tube. Biol Blood Marrow Transplant 2020;26:380-91. [PMID: 31622769 DOI: 10.1016/j.bbmt.2019.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
222 Jenq RR, van den Brink MR. Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice? Bone Marrow Transplant 2016;51:1071-2. [PMID: 27214076 DOI: 10.1038/bmt.2016.144] [Reference Citation Analysis]
223 Li Y, Chen HL, Bannick N, Henry M, Holm AN, Metwali A, Urban JF Jr, Rothman PB, Weiner GJ, Blazar BR, Elliott DE, Ince MN. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. J Immunol 2015;194:1011-20. [PMID: 25527786 DOI: 10.4049/jimmunol.1303099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
224 Rajagopala SV, Yooseph S, Harkins DM, Moncera KJ, Zabokrtsky KB, Torralba MG, Tovchigrechko A, Highlander SK, Pieper R, Sender L, Nelson KE. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genomics 2016;17:635. [PMID: 27527070 DOI: 10.1186/s12864-016-2965-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
225 Choe H, Ferrara JLM. New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD). Expert Opin Ther Targets 2021;25:761-71. [PMID: 34669521 DOI: 10.1080/14728222.2021.1992383] [Reference Citation Analysis]
226 Giaccone L, Faraci DG, Butera S, Lia G, Di Vito C, Gabrielli G, Cerrano M, Mariotti J, Dellacasa C, Felicetti F, Brignardello E, Mavilio D, Bruno B. Biomarkers for acute and chronic graft versus host disease: state of the art. Expert Rev Hematol 2021;14:79-96. [PMID: 33297779 DOI: 10.1080/17474086.2021.1860001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol 2017;35:1650-9. [PMID: 28296584 DOI: 10.1200/JCO.2016.70.3348] [Cited by in Crossref: 141] [Cited by in F6Publishing: 92] [Article Influence: 28.2] [Reference Citation Analysis]
228 Zhou Z, Shang T, Li X, Zhu H, Qi YB, Zhao X, Chen X, Shi ZX, Pan G, Wang YF, Fan G, Gao X, Zhu Y, Feng Y. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease. Front Physiol 2020;11:608279. [PMID: 33643058 DOI: 10.3389/fphys.2020.608279] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
229 Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J 2015;8:168-79. [PMID: 25815173 DOI: 10.1093/ckj/sfv004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
230 Devaux CA, Million M, Raoult D. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant. Front Microbiol 2020;11:1642. [PMID: 32793150 DOI: 10.3389/fmicb.2020.01642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
231 Vanholder R, Glorieux G, Massy ZA. Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations? Nephrol Dial Transplant 2016;31:1547-51. [PMID: 27190337 DOI: 10.1093/ndt/gfw040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
232 Salamonowicz-Bodzioch M, Frączkiewicz J, Czyżewski K, Zając-Spychała O, Gorczyńska E, Wróbel G, Kazanowska B, Sęga-Pondel D, Węcławek-Tompol J, Ussowicz M, Kałwak K, Wysocki M, Dziedzic M, Wachowiak J, Zaucha-Prażmo A, Kowalczyk J, Goździk J, Styczyński J. Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study. Ann Hematol 2021. [PMID: 34674000 DOI: 10.1007/s00277-021-04681-y] [Reference Citation Analysis]
233 Beckman MF, Morton DS, Bahrani Mougeot F, Mougeot JC. Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures. Support Care Cancer 2021;29:1765-79. [PMID: 33094358 DOI: 10.1007/s00520-020-05821-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Fuji S, Kapp M, Einsele H. Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Front Oncol 2014;4:89. [PMID: 24795865 DOI: 10.3389/fonc.2014.00089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
235 Horton LE, Haste NM, Taplitz RA. Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today? Curr Hematol Malig Rep 2018;13:59-67. [PMID: 29374371 DOI: 10.1007/s11899-018-0435-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
236 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
237 Biernat MM, Urbaniak-Kujda D, Dybko J, Kapelko-Słowik K, Prajs I, Wróbel T. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. J Int Med Res 2020;48:300060520925693. [PMID: 32527171 DOI: 10.1177/0300060520925693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
238 Qi X, Li X, Zhao Y, Wu X, Chen F, Ma X, Zhang F, Wu D. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study. Front Immunol 2018;9:2195. [PMID: 30319644 DOI: 10.3389/fimmu.2018.02195] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
239 de Berranger E, Charbonnier A, Davy E, Dendonker C, Denis V, Desmier D, Farrugia C, Guenounou S, Guilbert Y, Jost E, L'hostette A, Rialland F, Taque S, Yafour N, Seguy D, Yakoub Agha I. [Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2021:S0007-4551(21)00118-1. [PMID: 33966887 DOI: 10.1016/j.bulcan.2021.01.013] [Reference Citation Analysis]
240 Weber D, Oefner PJ, Hiergeist A, Koestler J, Gessner A, Weber M, Hahn J, Wolff D, Stämmler F, Spang R, Herr W, Dettmer K, Holler E. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood 2015;126:1723-8. [DOI: 10.1182/blood-2015-04-638858] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 16.3] [Reference Citation Analysis]
241 Turcotte LM, Yingst A, Verneris MR. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction. Biol Blood Marrow Transplant 2016;22:1159-66. [PMID: 27013015 DOI: 10.1016/j.bbmt.2016.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
242 Jiménez-Jorge S, Labrador-Herrera G, Rosso-Fernández CM, Rodríguez-Torres N, Pachón-Ibáñez ME, Smani Y, Márquez-Malaver FJ, Limón Ramos C, Solano C, Vázquez-López L, Kwon M, Mora Barrios JM, Aguilar-Guisado M, Espigado I; GETH (Grupo Español de Trasplante Hematopoyético y Terapia Celular). Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study. BMJ Open 2020;10:e034570. [PMID: 32690735 DOI: 10.1136/bmjopen-2019-034570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Cohen NA, Maharshak N. Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci. 2017;62:1131-1145. [PMID: 28315032 DOI: 10.1007/s10620-017-4535-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
244 Abboud R, Choi J, Ruminski P, Schroeder MA, Kim S, Abboud CN, DiPersio JF. Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease. Ther Adv Hematol 2020;11:2040620720914489. [PMID: 32537114 DOI: 10.1177/2040620720914489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
245 Wen Y, Jin R, Chen H. Interactions Between Gut Microbiota and Acute Childhood Leukemia. Front Microbiol 2019;10:1300. [PMID: 31275258 DOI: 10.3389/fmicb.2019.01300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
246 Greco R, Nitti R, Mancini N, Pasciuta R, Lorentino F, Lupo-Stanghellini MT, Barbanti MC, Clementi N, Giglio F, Clerici D, Marktel S, Assanelli A, Carrabba MG, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients. Blood 2021;137:1556-9. [PMID: 33171492 DOI: 10.1182/blood.2020007158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
247 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol 2020;27:360-7. [PMID: 33003084 DOI: 10.1097/MOH.0000000000000616] [Reference Citation Analysis]
249 Atilla E, Atilla PA, Bozdağ SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection 2017;45:403-11. [PMID: 28417421 DOI: 10.1007/s15010-017-1016-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
250 Georgel P. Innate immune receptors in solid organ transplantation. Human Immunology 2016;77:1071-5. [DOI: 10.1016/j.humimm.2016.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
251 Peric Z, Botti S, Stringer J, Krawczyk J, van der Werf S, van Biezen A, Aljurf M, Murray J, Liptrott S, Greenfield DM, Duarte RF, Ruutu T, Basak GW. Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 2018;53:1030-7. [PMID: 29515252 DOI: 10.1038/s41409-018-0137-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
252 Diefenbach CS, Peters BA, Li H, Raphael B, Moskovits T, Hymes K, Schluter J, Chen J, Bennani NN, Witzig TE, Ahn J. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma. Blood Adv 2021;5:1194-8. [PMID: 33635332 DOI: 10.1182/bloodadvances.2020003129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Malard F, Vekhoff A, Lapusan S, Isnard F, D'incan-Corda E, Rey J, Saillard C, Thomas X, Ducastelle-Lepretre S, Paubelle E, Larcher MV, Rocher C, Recher C, Tavitian S, Bertoli S, Michallet AS, Gilis L, Peterlin P, Chevallier P, Nguyen S, Plantamura E, Boucinha L, Gasc C, Michallet M, Dore J, Legrand O, Mohty M. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients. Nat Commun 2021;12:3084. [PMID: 34035290 DOI: 10.1038/s41467-021-23376-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
254 Hülsdünker J, Zeiser R. Insights into the pathogenesis of GvHD: what mice can teach us about man. Tissue Antigens 2015;85:2-9. [PMID: 25532439 DOI: 10.1111/tan.12497] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
255 Sano H, Hilinski JA, Qayed M, Applegate K, Newton JG, Watkins B, Chiang KY, Horan J. Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents. Pediatr Blood Cancer 2018;65. [PMID: 28921804 DOI: 10.1002/pbc.26821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
256 Gorshein E, Wei C, Ambrosy S, Budney S, Vivas J, Shenkerman A, Manago J, McGrath MK, Tyno A, Lin Y, Patel V, Gharibo M, Schaar D, Jenq RR, Khiabanian H, Strair R. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation. Clin Transplant 2017;31. [PMID: 28256022 DOI: 10.1111/ctr.12947] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
257 Lee MW, Yeon SH, Heo BY, Kwon J, Ryu H, Lee HJ, Yun HJ, Jo DY, Song IC. Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Hematology 2021;26:96-102. [PMID: 33459581 DOI: 10.1080/16078454.2021.1872957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
259 Nanayakkara AK, Boucher HW, Fowler VG Jr, Jezek A, Outterson K, Greenberg DE. Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward. CA Cancer J Clin 2021;71:488-504. [PMID: 34546590 DOI: 10.3322/caac.21697] [Reference Citation Analysis]
260 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Smibert O, Satlin MJ, Nellore A, Peleg AY. Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles. Curr Infect Dis Rep 2019;21:26. [PMID: 31183574 DOI: 10.1007/s11908-019-0679-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
262 de Koning C, Nierkens S, Boelens JJ. Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution. Blood 2016;128:2607-15. [PMID: 27697775 DOI: 10.1182/blood-2016-06-724005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
263 Andermann TM, Bhatt AS. Antibiotics in Hematopoietic Cell Transplantation: Adversaries or Allies? Biol Blood Marrow Transplant 2016;22:972-4. [PMID: 27095689 DOI: 10.1016/j.bbmt.2016.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
264 Manzo VE, Bhatt AS. The human microbiome in hematopoiesis and hematologic disorders. Blood 2015;126:311-8. [PMID: 26012569 DOI: 10.1182/blood-2015-04-574392] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
265 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med. 2015;13:275. [PMID: 26298517 DOI: 10.1186/s12967-015-0640-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
266 Yafour N, Serradj F, Osmani S, Brahimi M, Bouhass R, Arabi A, Bazarbachi A, Bekadja MA. Improving survival rates for patients with acute myeloid leukemia: Impacts of fludarabine/busulfan and antithymocyte globulin as reduced toxicity myeloablative conditioning for matched related donor allo-HCT. Curr Res Transl Med 2020;68:145-8. [PMID: 33028507 DOI: 10.1016/j.retram.2020.09.001] [Reference Citation Analysis]
267 Koh AY. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. Clin Chem 2017;63:1685-94. [PMID: 28720679 DOI: 10.1373/clinchem.2016.259499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
268 Hill L, Alousi A, Kebriaei P, Mehta R, Rezvani K, Shpall E. New and emerging therapies for acute and chronic graft versus host disease. Ther Adv Hematol. 2018;9:21-46. [PMID: 29317998 DOI: 10.1177/2040620717741860] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
269 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
270 Goeser F, Sifft B, Stein-Thoeringer C, Farowski F, Strassburg CP, Brossart P, Higgins PG, Scheid C, Wolf D, Holderried TAW, Vehreschild MJGT, Cruz Aguilar MR. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers. Eur J Haematol 2021;107:229-45. [PMID: 33934412 DOI: 10.1111/ejh.13642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 2016;122:2186-96. [PMID: 27142181 DOI: 10.1002/cncr.30039] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
272 Riwes M, Reddy P. Microbial metabolites and graft versus host disease. Am J Transplant 2018;18:23-9. [PMID: 28742948 DOI: 10.1111/ajt.14443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
273 Zhang J, Ren G, Li M, Lu P, Yi S. The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation. Case Rep Hematol 2019;2019:4505238. [PMID: 31049232 DOI: 10.1155/2019/4505238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
274 Wang J, Li X, Wu X, Wang Z, Zhang C, Cao G, Liu S, Yan T. Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation. Appl Microbiol Biotechnol 2021;105:2473-84. [PMID: 33625548 DOI: 10.1007/s00253-020-11069-x] [Reference Citation Analysis]
275 Lindell RB, Gertz SJ, Rowan CM, McArthur J, Beske F, Plunkett A, Weiss SL, Thomas NJ, Nadkarni VM, Fitzgerald JC; Sepsis PRevalence, OUtcomes, and Therapies Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. High Levels of Morbidity and Mortality Among Pediatric Hematopoietic Cell Transplant Recipients With Severe Sepsis: Insights From the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study. Pediatr Crit Care Med 2017;18:1114-25. [PMID: 28926489 DOI: 10.1097/PCC.0000000000001338] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
276 Aversa F, Prezioso L, Manfra I, Galaverna F, Spolzino A, Monti A. Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis 2016;8:e2016057. [PMID: 27872737 DOI: 10.4084/MJHID.2016.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
277 Rattanathammethee T, Tuitemwong P, Thiennimitr P, Sarichai P, Na Pombejra S, Piriyakhuntorn P, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Tantiworawit A, Norasetthada L. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS One 2020;15:e0236460. [PMID: 33112882 DOI: 10.1371/journal.pone.0236460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB, Hoda D. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2016;18:628-633. [PMID: 27214585 DOI: 10.1111/tid.12550] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
279 Lee KA, Luong MK, Shaw H, Nathan P, Bataille V, Spector TD. The gut microbiome: what the oncologist ought to know. Br J Cancer 2021. [PMID: 34262150 DOI: 10.1038/s41416-021-01467-x] [Reference Citation Analysis]
280 Lupsa N, Szegedi Á, Gézsi A, Vuncs Z, Masszi T, Mikala G, Reményi P, Deola S, Lakshmanan AP, Terranegra A, Buzás EI, Pós Z. Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement. Biomedicines 2022;10:519. [DOI: 10.3390/biomedicines10030519] [Reference Citation Analysis]
281 Biagi E, Zama D, Nastasi C, Consolandi C, Fiori J, Rampelli S, Turroni S, Centanni M, Severgnini M, Peano C, de Bellis G, Basaglia G, Gotti R, Masetti R, Pession A, Brigidi P, Candela M. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant 2015;50:992-8. [PMID: 25893458 DOI: 10.1038/bmt.2015.16] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 9.4] [Reference Citation Analysis]
282 Daoud-Asfour H, Henig I, Ghersin I, Rakedzon S, Stern A, Pitashny M, Zuckerman T, Bar-Yoseph H. Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure. Transplant Cell Ther 2021:S2666-6367(21)01445-7. [PMID: 34954293 DOI: 10.1016/j.jtct.2021.12.012] [Reference Citation Analysis]
283 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Hematology Am Soc Hematol Educ Program 2016;2016:119-27. [PMID: 27913470 DOI: 10.1182/asheducation-2016.1.119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
284 Teshima T, Reddy P, Zeiser R. Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:11-6. [PMID: 26453971 DOI: 10.1016/j.bbmt.2015.10.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
285 Shono Y, van den Brink MRM. Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? Blood Adv 2017;1:2325-8. [PMID: 29296882 DOI: 10.1182/bloodadvances.2017005108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
286 Dutta D, Lim SH. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomark Res. 2020;8:31. [PMID: 32817793 DOI: 10.1186/s40364-020-00211-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
287 Adom D, Rowan C, Adeniyan T, Yang J, Paczesny S. Biomarkers for Allogeneic HCT Outcomes. Front Immunol 2020;11:673. [PMID: 32373125 DOI: 10.3389/fimmu.2020.00673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
288 Wolff D, Hildebrandt GC. Bronchiolitis Obliterans: Pleading for a Pragmatic Approach. Biology of Blood and Marrow Transplantation 2016;22:591-3. [DOI: 10.1016/j.bbmt.2016.01.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
289 Clemmons AB, Bech CF, Pantin J, Ahmad I. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime. Biology of Blood and Marrow Transplantation 2018;24:820-6. [DOI: 10.1016/j.bbmt.2017.12.799] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
290 Henden AS, Hill GR. Cytokines in Graft-versus-Host Disease. J Immunol. 2015;194:4604-4612. [PMID: 25934923 DOI: 10.4049/jimmunol.1500117] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 15.1] [Reference Citation Analysis]
291 Harusato A, Chassaing B. Insights on the impact of diet-mediated microbiota alterations on immunity and diseases. Am J Transplant 2018;18:550-5. [PMID: 28858426 DOI: 10.1111/ajt.14477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
292 Vasconcelos RM, Sanfilippo N, Paster BJ, Kerr AR, Li Y, Ramalho L, Queiroz EL, Smith B, Sonis ST, Corby PM. Host-Microbiome Cross-talk in Oral Mucositis. J Dent Res 2016;95:725-33. [PMID: 27053118 DOI: 10.1177/0022034516641890] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
293 Bertolini M, Ranjan A, Thompson A, Diaz PI, Sobue T, Maas K, Dongari-Bagtzoglou A. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection. PLoS Pathog 2019;15:e1007717. [PMID: 31009520 DOI: 10.1371/journal.ppat.1007717] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 19.3] [Reference Citation Analysis]
294 Pereira AZ, Vigorito AC, Almeida AM, Candolo AA, Silva ACL, Brandão-Anjos AEP, Sá BL, Souza CLS, Castro Junior CG, Oliveira JSR, Barban JB, Mancilha EMB, Todaro J, Lopes LP, Macedo MCMA, Rodrigues M, Ribeiro PC, Silva RLD, Roberto TS, Rodrigues TCR, Colturato VAR, Paton EJA, Barros GMN, Almeida RDS, Moreira MCR, Flowers ME. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease. Einstein (Sao Paulo) 2020;18:eAE4799. [PMID: 32215466 DOI: 10.31744/einstein_journal/2020AE4799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
295 Ciftciler R, Ciftciler AE. The importance of microbiota in hematology. Transfus Apher Sci 2021;:103320. [PMID: 34801432 DOI: 10.1016/j.transci.2021.103320] [Reference Citation Analysis]
296 Masetti R, Zama D, Leardini D, Muratore E, Turroni S, Prete A, Brigidi P, Pession A. The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2020;67:e28711. [PMID: 32939928 DOI: 10.1002/pbc.28711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
297 Rearigh L, Stohs E, Freifeld A, Zimmer A. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia. Ann Hematol 2020;99:1917-24. [PMID: 32556455 DOI: 10.1007/s00277-020-04132-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
298 Andermann TM, Rezvani A, Bhatt AS. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep 2016;11:19-28. [PMID: 26780719 DOI: 10.1007/s11899-016-0302-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
299 Jahan D, Peile E, Sheikh MA, Islam S, Parasnath S, Sharma P, Iskandar K, Dhingra S, Charan J, Hardcastle TC, Samad N, Chowdhury TS, Dutta S, Haque M. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation. Expert Rev Anti Infect Ther 2021;:1-22. [PMID: 33711240 DOI: 10.1080/14787210.2021.1902304] [Reference Citation Analysis]
300 Elgarten CW, Tanes C, Lee JJ, Danziger-Isakov LA, Grimley MS, Green M, Michaels MG, Barnum JL, Ardura MI, Auletta JJ, Blumenstock J, Seif AE, Bittinger KL, Fisher BT. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 2021;:e29384. [PMID: 34709713 DOI: 10.1002/pbc.29384] [Reference Citation Analysis]
301 Ranjan A, Dongari-Bagtzoglou A. Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments. J Fungi (Basel) 2018;4:E112. [PMID: 30231476 DOI: 10.3390/jof4030112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
302 Lee A, Hong J, Shin DY, Koh Y, Yoon SS, Kim PJ, Kim HG, Kim I, Park HK, Choi Y. Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. J Clin Med 2020;9:E1090. [PMID: 32290456 DOI: 10.3390/jcm9041090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Reikvam H, Grønningsæter IS, Mosevoll KA, Lindås R, Hatfield K, Bruserud Ø. Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers. Front Immunol 2017;8:1979. [PMID: 29416533 DOI: 10.3389/fimmu.2017.01979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
304 Weber D, Oefner PJ, Dettmer K, Hiergeist A, Koestler J, Gessner A, Weber M, Stämmler F, Hahn J, Wolff D, Herr W, Holler E. Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 2016;51:1087-92. [PMID: 26999466 DOI: 10.1038/bmt.2016.66] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]